{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-002906","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2026-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.261964+00:00","generated_at":"2026-05-16T05:57:11.158358+00:00","sec_items":["1.01","3.02","3.03","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nuwellis raises $5M in private placement and warrant inducement; acquires Rendiatech; appoints new CFO","bullets":["Gross proceeds ~$5M from private placement (994,537 shares/pre-funded + 1,989,074 warrants) and warrant inducement (623,585 shares exercised, 1,247,170 new warrants).","Agreement to acquire Rendiatech Ltd. for up to $500K cash + 150,000 shares + 30,000 options; Clarity RMS/Prime real-time kidney monitoring tech.","Appointed Carisa Schultz as CFO effective Feb 2, 2026; base salary $265K, bonus up to 40%, standard change-in-control severance.","Company had 1,686,892 shares outstanding as of Jan 29, 2026; warrants add significant potential dilution.","Net proceeds for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-002906","json":"https://secwatch.observer/filing/0001140361-26-002906.json","markdown":"https://secwatch.observer/filing/0001140361-26-002906.md","text":"https://secwatch.observer/filing/0001140361-26-002906.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126002906/0001140361-26-002906-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126002906/ny20058654x4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:57:11.158358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a081e3f28729d64e1630c7024655a092425cc1bd","claim":"Nuwellis, Inc. entered into Private Placement Purchase Agreement with a certain institutional accredited investor valued at combined purchase price of $3.09 (effective 2026-01-29).","evidence_excerpt":"On January 29, 2026, Nuwellis, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Private Placement Purchase Agreement ”) with a certain institutional accredited investor (the “ Purchaser ”) in connection with a private placement (the “ Private Placement ”) for the offer, issuance and sale of (i) 994,537 pre-funded common stock purchase warrants (the “ Pre-Funded Warrants ”) to purchase up to 994,537 shares (the “ Pre-Funded Warrant Shares ”) of the Company’s common stock, $0.0001 par value (the “ Common Stock ”) and (ii) 1,989,074 common warrants (the “ Common Warrants ”, and together with the Pre-Funded Warrants, the “ Private Placement Warrants ”) to purchase up to 1,989,074 shares of Common Stock (the “ Common Warrant Shares ” and together with the Pre-Funded Warrant Shares and the Pre-Funded Warrants, the “ Securities ”) for a combined purchase price of $3.09.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506492/000114036126002906/0001140361-26-002906-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain institutional accredited investor"},{"label":"Value","value":"combined purchase price of $3.09"},{"label":"Effective","value":"2026-01-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}